Therefore, the prospect exists that the signature CD103+Vγ4+ gut T cell phenotype might also be disrupted by other factors of the IBD milieu that we have not tested, including reported reductions in BTNL3+BTNL8 expression (15, 46). This evidence concerns the gene BTNL3 and inflammatory bowel disease.